Skip to main content
Cureus logoLink to Cureus
. 2021 Oct 29;13(10):e19136. doi: 10.7759/cureus.19136

Safety of Venous Thromboembolism Prophylaxis Protocol Using a Novel Leg Exercise Apparatus in Bedridden Patients due to Spinal Diseases

Kanami Kobayashi 1,2, Yukiyo Shimizu 2,, Ayumu Haginoya 2, Yasushi Hada 2, Masashi Yamazaki 3
Editors: Alexander Muacevic, John R Adler
PMCID: PMC8629692  PMID: 34868774

Abstract

Purpose: Venous thromboembolism (VTE) is a complication in patients with a spinal disease requiring bedfast for conservative therapies. We previously developed a novel leg exercise apparatus (LEX) to encourage patients to exercise their lower extremities during bed rest. The purpose of this study was to evaluate the feasibility and safety of the LEX for the prevention of VTE in patients on bed rest due to spinal disease.

Methods: Patients with spinal diseases requiring bed rest were included in the study. Exercise using the LEX was performed for ≥5 minutes. The exercises were performed three or more times per day during the bed rest period. In addition, we evaluated adverse events, such as symptomatic VTE and changes in vital signs, using venous ultrasonography, blood tests, and measurement of vital signs.

Results: In total, 31 patients were enrolled (11 men, 20 women), with mean age, height, weight, and body mass index of 72.4 years, 155.2 cm, 55.0 kg, and 22.6 kg/m2, respectively. Twenty-four subjects had spinal fractures. Twenty-nine patients continued exercising until they could leave their beds. No symptomatic VTE was observed in any patient, and no other severe adverse events were observed. There were no significant changes in vital signs. The average number of exercise days with LEX and length of hospitalization were 11 and 31 days, respectively.

Conclusions: This is the first study regarding mechanical thromboprophylaxis through in-bed exercise for patients with bedridden spinal disease. The LEX exercise protocol, in addition to mechanical prophylaxis with graduated compression stockings and intermittent pneumatic compression devices, for the prevention of symptomatic VTE may be feasible and safe for patients with bedridden spinal disease.

Keywords: spinal disease, bed rest, symptomatic venous thromboembolism, venous thromboembolism prophylaxis, leg exercise apparatus

Introduction

Venous thromboembolism (VTE) is a crucial problem for bedridden patients. Ota et al. studied the incidence of VTE and reported its remarkable increase in Japan from 1996 to 2011 [1]. In particular, orthopedic patients are at a higher risk of VTE among all patients, and those who undergo spinal surgery are at risk of VTE [2-5]. Moreover, patients who underwent spine fracture surgery have a higher VTE rate of 9.2% than that of other spine patients' VTE rate of 2.3%. [6]. A longer hospital stay and older age are associated with greater risks of VTE events among patients with spinal fractures [7].

Mechanical and pharmacological thromboprophylaxis is recommended in the guidelines of the American College of Chest Physicians (ACCP) [8]. However, pharmacological prophylaxis does not apply to patients with a risk of bleeding [8]. Mechanical prophylaxis is recommended rather than pharmacological methods for patients undergoing spinal surgery to prevent bleeding complications. Mechanical prophylaxis includes graduated compression stockings (GCS), intermittent pneumatic compression device (IPCD), early ambulation, and voluntary lower extremity exercises. Mechanical thromboprophylaxis focuses on the stasis of blood flow, which is one of Virchow’s triad [9,10]. The major disadvantage of GCS and IPCD is poor patient compliance [9]. Patients may have difficulties continuing to use these devices due to side effects such as lower extremity pain and skin problems, including pressure ulcers and itching [9]. It is difficult to get out of bed early in patients with spinal fractures or before spinal surgery because they are forced to be bedfast for treatment. Although we recommend voluntary lower extremity exercises to prevent VTE, patients with spinal disease rarely perform leg exercises voluntarily. Therefore, we developed a novel leg exercise apparatus (LEX) that helps patients move their lower extremities voluntarily [11-14]. We found that a brief period of exercise using the LEX increased venous flow in the lower extremities compared with the continuous use of IPCD [12].

This study aimed to evaluate the feasibility and safety of using a novel LEX for the prevention of VTE in bedridden patients with spinal diseases.

Materials and methods

Ethical consideration

This study was carried out as per the principles of the Declaration of Helsinki and was approved by the institutional review board of the hospital (No. H29-182). All participants provided verbal and written informed consent before completing any study-related tasks.

Participants

Patients with a spinal disease requiring bed rest were enrolled between January 2019 and May 2021. The exclusion criteria were as follows: 1) patients with a history of proximal deep vein thrombosis (DVT); 2) patients with spinal instability even in bedfast positions; 3) patients with a cerebral aneurysm or dissecting aortic aneurysm, wherein an increase in blood pressure may aggravate their general condition; 4) patients with severe complications (e.g., heart disease, liver disease, and kidney disease); 5) patients who were pregnant or suspected of being pregnant; 6) patients who were unable to consent voluntarily; and 7) others who were considered ineligible by the attending physician.

Leg exercise apparatus (LEX)

The LEX is a device developed to facilitate active lower extremity exercise and consequently prevent VTE. Patients can perform leg exercises effectively using the LEX as it was designed to perform leg exercises in the supine position (Figure 1) [11-14]. The device is made up of right and left pedals and a motion control mechanism, which can be placed on the bed and fixed to the backboard of the bed by hooks. The feet are fixed to the pedal using shoes. The patient’s ankles can move up to 30° dorsiflexion, 60° plantar flexion, 30° subtalar inversion, and 20° subtalar eversion when the feet are fixed on the pedal. The LEX does not inhibit the performance of the ankle, knee, and hip joints. We tried to maintain the patients’ knee flexion position during exercises with the LEX to make contraction of the soleus muscle dominant over that of the gastrocnemius muscle.

Figure 1. The LEX .

Figure 1

The LEX is made up of right and left pedals, shoes, a metal base, hooks, and a motion control mechanism.

LEX: Leg exercise apparatus

Primary outcomes

To investigate the feasibility and safety of performing exercises with the LEX, we evaluated the presence or absence of adverse events related to exercise using the LEX. We assessed symptomatic VTE and other adverse events, such as death, death from complications, and prolonged hospital stay, to treat complications and disability due to complications.

The presence of DVT was assessed by ultrasonography of the lower extremities and blood tests, including D-dimer levels, both before starting the LEX protocol and after the LEX protocol.

Secondary outcome

To investigate the feasibility of exercises with the LEX, we measured the effect on circulatory dynamics, including blood pressure, pulse rate, and percentage saturation of oxygen before and after exercise on the first and last days of the exercise. In addition, the maximum calf circumference and the thigh circumference 10 cm above the patella were measured on the first and last days of exercise. Moreover, the degree of fatigue was evaluated using the modified Borg scale, before and after LEX exercise in both first and last sessions (Table 1) [15].

Table 1. The modified Borg scale - a subjective estimate of the degree of fatigue.

Modified Borg scale
0 No breathlessness
0.5 Very, very slight (just noticeable)
1 Very slight
2 Slight breathlessness
3 Moderate
4 Somewhat severe
5 Severe breathlessness
6  
7 Very severe breathlessness
8  
9 Very, very severe (almost maximum)
10 Maximum

Statistical analyses

Paired t-tests were performed to compare D-dimer levels before and after the LEX intervention, changes in vital sign changes (systolic and diastolic blood pressure, pulse rate, and percentage saturation of oxygen) before and after LEX use on the first and last days of exercise, and circumferences of both the calf and thigh on the first and last days of the LEX intervention. Modified Borg Scales before and after LEX use on the first and last days were tested using the Wilcoxon signed-rank test. Statistical significance was set at p<0.05. Analyses were performed using JMP 14.3.0 (SAS Institute Inc., Cary, NC, USA).

Intervention

Participants performed active leg exercises using the LEX in the supine position to avoid load on the spine and spine torsion and to maintain the stability of the spinal column. We evaluated whether each participant could easily move their legs while in the supine position and would, if necessary, place a cushion under their knees to increase the ease at which they could move their legs. We did not set the pace for exercises using the LEX. Instead, participants determined the pace at which they could comfortably move their legs. The exercise sessions lasted for at least five minutes and were repeated three times a day. Shimizu et al. showed that one minute of exercise with the LEX had a lasting effect of 30 minutes and stated that she would conduct a future exercise with the LEX four times a day for five minutes each time [15]. In this study, we decided that these exercise sessions should be five minutes in duration. However, the number of sessions was limited to three per day, as this was considered feasible in our clinical setting. Physical therapists and nurses or assistant nurses supervised the sessions once a day and twice per day on weekdays, respectively. The patients performed the exercises under the supervision of nurses or assistant nurses three times a day on weekends. The exercise program started after confirming there was no symptomatic VTE and finished when patients could get out of bed or thereafter. A physician or physical therapist supervised the first exercise session and guided how to perform the exercises correctly to avoid improper movements. A physician or physical therapist also decided how to set the device and cushion and explained the optimal position of the participant to the nurses.

Management and assessment to prevent VTE during the bed rest period

Assessments and exercises were conducted following the procedure shown in Table 2.

Table 2. Interventional procedures.

LEX: Leg exercise apparatus

Day Procedure
Pre LEX Informed consent
D-dimer  
Ultrasonography
Practice exercise using LEX
The first day of LEX (before LEX) Blood pressure, pulse rate, and percentage saturation of oxygen
Modified Borg scale
The first day of LEX  (after LEX) Blood pressure, pulse rate, and percentage saturation of oxygen
Modified Borg scale
LEX period Exercise using LEX three times per day
Before the last day of LEX D-dimer  
Ultrasonography
The last day of LEX (before LEX) Blood pressure, pulse rate, and percentage saturation of oxygen
Modified Borg scale
The last day of LEX (after LEX) Blood pressure, pulse rate, and percentage saturation of oxygen
Modified Borg scale

Graduated compression stockings were used in all cases to prevent VTE, while IPCD was also used in cases considered without DVT. Due to atrial fibrillation, edoxaban was used in one case, and rivaroxaban was used in another. The participants used GCS for the entire bed rest period. The IPCD was detached during exercise with LEX.

Cancellation criteria

Patients were excluded from the study if any of the following events occurred: 1) adverse events that make it difficult to continue research; 2) requests from the patient to withdraw from participation in the study; 3) withdrawal of consent for participation in the study; 4) discovery of continuous violations to the study plan; 5) judgment on discontinuation by the attending physician for some reason.

Results

In total, 31 patients were enrolled, including 11 men and 20 women, with a mean age, height, weight, and body mass index (BMI) of 72.4 years (range: 22 to 91 years), 155.2 cm (range: 142 to 171 cm), 55.0 kg (range: 35.0 to 100.7 kg), and 22.6 kg/m2 (range: 15.4 to 34.8 kg/m2), respectively (Table 3). None of the patients met any of the exclusion criteria, and all consented to participate in the study. Twenty-four patients had spinal fractures. Overall, 29 of the 31 patients completed the exercise regimen. No serious adverse events occurred during the study period. The average number of LEX exercise days was 11 (range: three to 33 days), and the average length of hospitalization was 31 days (range: 13 to 64 days).

Table 3. Background of the patients enrolled in this study.

BMI: Body mass index

Subject Sex Age Height [cm] Weight [kg] BMI [kg/m2] Diagnosis Surgery
1 Female 63 143.0 44.9 22.0 Postoperative infection (Th9,10) +
2 Male 76 165.0 76.0 27.9 Vertebral fracture (Th9) +
3 Male 76 168.0 52.8 18.7 Vertebral fracture (L1) +
4 Male 80 171.0 67.0 22.9 Myelopathy (C4,5) +
5 Female 64 151.5 56.0 24.4 Vertebral fracture (Th6) +
6 Female 77 144.0 49.6 23.9 Vertebral fracture (Th12) +
7 Female 63 151.0 44.2 19.4 Vertebral fracture (Th12) -
8 Male 86 165.0 64.5 23.7 Vertebral fracture (Th4) -
9 Female 75 152.0 63.5 27.5 Vertebral fracture (L1) -
10 Female 83 151.2 36.6 16.0 Vertebral fracture (Th12) -
11 Female 85 142.0 42.4 21.0 Vertebral fracture (L1) -
12 Female 91 144.0 42.1 20.3 Vertebral fracture (L1) -
13 Male 84 160.0 45.3 17.7 Vertebral fracture (L1) +
14 Female 70 154.0 52.0 21.9 Vertebral fracture (L1) -
15 Male 65 165.0 77.2 28.4 Vertebral fracture (L4) -
16 Male 67 164.4 63.4 23.5 Vertebral metastasis (Th4.5.6) +
17 Female 78 151.0 35.0 15.4 Pseudoarthrosis (L2) +
18 Female 67 153.0 62.0 26.5 Vertebral fracture (Th10) +
19 Female 72 148.0 38.4 17.5 Vertebral osteomyelitis (L4.5) +
20 Female 79 151.2 49.1 21.5 Vertebral fracture (L1) -
21 Female 69 149.0 51.9 23.4 Vertebral fracture (Th9) +
22 Male 80 152.5 57.1 24.6 Vertebral fracture (L1) -
23 Male 71 158.8 55.1 21.8 Vertebral fracture (Th12) +
24 Male 60 166.0 67.8 24.6 Vertebral fracture (Th12) -
25 Female 71 154.0 52.0 21.9 Vertebral fracture (Th11, L1) -
26 Female 76 156.0 39.2 16.1 Vertebral fracture (L1) -
27 Female 72 155.0 45.7 19.0 Vertebral osteomyelitis (L4.5) -
28 Female 82 149.3 53.4 24.0 Vertebral fracture (Th7) -
29 Male 59 170.2 100.7 34.8 Ossification of ligamentum flavum (Th10, 11) +
30 Female 22 160.0 59.0 23.0 Vertebral fracture (L1,3,4) -
31 Female 81 147.0 60.2 27.9 Vertebral fracture (S) -

No symptomatic VTEs were observed following the LEX protocol. Twenty of the 31 patients underwent ultrasonography of the lower extremities before getting out of the bed due to the risk of blood clots, and no new DVTs were observed. The mean D-dimer level before the LEX program was 7.1 μg/mL, whereas the corresponding value following the LEX program was 3.2 μg/mL (Figure 2). Paired t-test analysis did not show a significant difference in D-dimer levels before or after LEX treatment (p=0.173).

Figure 2. Changes in D-dimer level before starting the LEX protocol and after the LEX protocol.

Figure 2

LEX: Leg exercise apparatus

The average systolic blood pressure, diastolic blood pressure, pulse rate, and SpO2 changed from 130.4 to 130.9 mmHg, 78.0 to 79.9 mmHg, 78.8 to 78.9 bpm, and 96.9 to 96.8 %, respectively, before and after the first exercise session. The average systolic blood pressure, diastolic blood pressure, and pulse rate changed from 125.5 to 127.1 mmHg, 69.9 to 70.4 mmHg, and 74.7 to 76.7 bpm, respectively, while the average SpO2 did not change, before and after the last exercise session. Table 4 shows the mean circulatory dynamics, including blood pressure, pulse rate, and percentage saturation of oxygen. Paired t-test analysis showed a significant difference in diastolic blood pressure before and after the first exercise session (p=0.047).

Table 4. Comparison of blood pressure, pulse rate, and the percentage saturation of oxygen before and after exercise using the LEX in the first and last exercise sessions.

Data are presented as mean. Paired t-tests were performed. *p <0.05.

'Before' column features data collected before the LEX exercise. 'After' column features data collected after the LEX exercise.

sBP: Systolic blood pressure; dBP: Diastolic blood pressure; PR: Pulse rate; SpO2: Saturation of percutaneous oxygen; LEX: Leg exercise apparatus

BP, PR, and SpO2 in the first exercise session
  Before After p-value N
sBP [mmHg] 130.4 131.6 0.446 28
dBP [mmHg] 78.0 80.5 0.047* 27
PR [bpm] 78.8 79.4 0.445 28
SpO2 [%] 96.9 96.9 1.000 26
BP, PR, and SpO2 in the last exercise session
  Before After p-value N
sBP [mmHg] 125.5 127.1 0.152 18
dBP [mmHg] 69.9 70.4 0.667 18
PR [bpm] 74.7 76.7 0.132 18
SpO2 [%] 97.8 97.8 1.000 18

Circumference of the lower limbs in the first and last exercise sessions was assessed (Table 5.). The average maximum right and left calf circumferences changed from 30.1 to 30.7 cm and 30.2 to 30.8 cm, respectively, between the first and last exercise sessions. The average right and left thigh circumference 10 cm above the patella changed from 37.6 to 38.5 cm and 37.6 to 38.2 cm, respectively. Paired t-test analysis did not show a significant difference in the circumference of the lower limbs between the first and last exercise sessions using LEX.

Table 5. Comparison of the maximum calf circumference and the thigh circumference 10 cm above the patella on the first day and the last day of the LEX exercise.

Data are presented as mean. Paired t-test was performed; p*<0.05.

'First day' column features data collected on the first day of the LEX exercise. 'Last day' column features data collected on the last day of the LEX exercise.

The maximum circumference of the calf was taken. The thigh circumference was taken 10 cm above the patella.

  First day Last day p-value N
Right calf [cm] 30.9 30.7 0.780 22
Left calf [cm] 31.0 30.8 0.672 22
Right thigh [cm] 38.7 38.5 0.277 22
Left thigh [cm] 38.7 38.2 0.071 22

During the first exercise session, the average modified Borg scale scores for breaths and legs changed from 0.73 to 1.45 and 1.13 to 2.43, respectively. During the last exercise session, the average modified Borg scale scores for breath and legs changed from 0.55 to 0.71 and 0.55 to 0.95, respectively. Table 6 shows the median data regarding the modified Borg scale and p-values obtained using the Wilcoxon signed-rank test. The Wilcoxon signed-rank test showed a significant difference in the modified Borg scale scores for breaths and legs before and after exercise in the first exercise session (p=0.001 and p<0.001, respectively). A significant difference was also observed in the modified Borg scale scores for legs before and after exercise in the last exercise session (p=0.015).

Table 6. Comparison of the modified Borg scale before and after exercise using LEX in the first and last exercise sessions.

Data are presented as median. The Wilcoxon signed-rank test was performed; p*<0.05.

'Before' column features data collected before the LEX exercise. 'After' column features data collected after the LEX exercise.

Modified Borg scale in the first exercise session
  Before After p-value N
Breath 0 0.75 0.001* 28
Leg 0.25 2 <0.001* 28
Modified Borg scale in the last exercise session
  Before After p-value N
Breath 0 0 0.090 21
Leg 0 1 0.015* 21

Details of D-dimer levels, blood pressure, pulse rate, percentage oxygen saturation, lower extremity circumference, and modified Borg scale scores are shown in Appendix A.

Discussion

In this study, all patients were able to perform the LEX exercise program without severe adverse events, including symptomatic VTE. Twenty-nine of the 31 enrolled patients completed the program. One patient withdrew due to back pain. She could not follow the rest of the instructions and, as such, walked around her room during the bed rest period. Another patient could not complete the program due to exacerbation of chronic renal failure. Although it is important to continue active lower extremity exercises to prevent thrombosis in patients with chronic renal failure, it was difficult for this patient to continue the exercises with the LEX due to the worsening of her general condition and the introduction of dialysis treatment. She only exercised using the LEX twice due to low motivation before the worsening of her chronic renal failure. Therefore, we did not think that the LEX exercise had a negative effect on her general condition. Active lower extremity exercise with LEX is considered painless for patients whose general condition is calm and who can observe the resting level restriction. Due to the limited pain during LEX exercise, it might be feasible to introduce this method to patients who are required to stay in bed.

Twenty-four of the 31 patients had vertebral fractures, and their average age was 74 years. They could perform lower limb exercises, including ankle movements during the bed rest period. Twenty-three patients did not complain of pain during LEX exercise. Vertebral fractures are more common in the elderly, such as the patients in this study, and they are at a high risk of thromboembolism [5,16-18]. Nonetheless, no symptomatic thrombi were observed in this study. Moreover, some patients with vertebral fractures requiring bedfast for conservative therapies hoped to perform LEX exercises for a longer time and longer period. We hope that they enjoyed the exercises and realized the importance of VTE prevention. In addition, the recommended treatment for vertebral fractures varies according to guidelines, and the optimal method is not clear [19]. Surgical treatment allows early ambulation, and voluntary lower extremity exercises with LEX may be unnecessary. However, there is a concern that the bed rest period may be prolonged with a longer surgical waiting period, when patients cannot be released immediately after surgery or when conservative therapy is used. In such cases, the LEX may motivate patients to perform voluntary lower extremity exercises, which may be useful for thromboprophylaxis. Based on these facts, it seems useful to introduce the LEX exercise program to patients with vertebral fractures to encourage them to move their legs during the bed rest period.

This study protocol was considered feasible and safe. The risk of VTE in elective spinal surgery patients ranges from 0% to 31% [4]. Neither severe adverse events nor symptomatic VTE occurred in this study, and over 90% of the patients completed the protocol. Average D-dimer levels around the end of the LEX program were much lower than those prior to completing the LEX program. The decrease in D-dimer levels may be due to a period post-injury, but it could also result from exercise using the LEX. Diastolic blood pressure was significantly different before and after the first exercise session. There was also a significant difference in the modified Borg scale scores for breath and legs before and after the first exercise session and for legs before and after the last exercise session. However, no clinically significant changes in vital signs were observed before and after exercise in both first and last sessions. The criteria for discontinuation of rehabilitation by the Japanese Association of Rehabilitation Medicine include tachycardia of ≥140 bpm and increases in systolic and diastolic blood pressure of 40 and 20 mmHg or more, respectively, during exercise [20]. In this study, no patients reached these discontinuation criteria during the first or last LEX session.

Both mechanical and pharmacological methods are recommended to prevent VTE [8]. However, it is difficult to perform pharmacological thromboprophylaxis in patients with bleeding risk, such as those undergoing spinal surgery. Therefore, the LEX may be useful with regards to strengthening mechanical thromboprophylaxis [5].

Cancer patients and pregnant women are at a high risk of VTE [21,22]. Therefore, they may be less active. We would like to use the LEX for patients with other diseases, such as cancer or pregnant women, and evaluate its usefulness.

Finally, the world is currently facing a pandemic. Coronavirus disease 2019 (COVID-19) has become a pandemic and increased the risk of VTE [23]. Moreover, COVID-19 is an infectious disease that requires isolation, reducing the chances of getting out of bed and rehabilitation and increasing the risk of VTE. Patients can exercise using the LEX by themselves, which may help prevent VTE and secure opportunities for exercise instead of rehabilitation.

There are some limitations to this study. First, it is difficult to prove the effectiveness of the LEX in preventing VTE because the sample size was too small. Second, the effectiveness of the LEX alone is unclear because, in this single-arm study, we used other thrombosis prevention devices, including GCS and IPCD. Third, we would like to study the effect of LEX exercise on maintaining muscle strength or activities of daily living improvement in the future. Finally, for the LEX to become more popular, some improvements are needed. For example, it should be made lighter and easier to be set up by patients themselves.

Conclusions

This is the first study regarding mechanical thromboprophylaxis through in-bed exercise for patients with spinal disease who are required to be bedfast. Exercises using the LEX for bedfast patients due to spinal disease were well accepted and associated with no severe adverse events. Additionally, no symptomatic VTE occurred in these patients. The results of this study suggest that the protocol of exercise with the LEX to prevent symptomatic VTE is feasible and safe in patients on bed rest due to spinal disease. Therefore, we believe that exercises using the LEX can be useful for patients on bed rest due to various diseases. Moreover, not only medical experts but also patients could notice the importance of voluntary leg movement for thromboembolism prophylaxis through exercise using the LEX.

Appendices

Appendix A

Table 7. The data of D-dimer level before starting the LEX protocol and after the LEX protocol.

Blank space means that no data was measured.

LEX: Leg exercise apparatus

  Before starting the LEX protocol After the LEX protocol
Subject D-dimer D-dimer
1 4.3 4.1
2 7.9  
3 5.6 1.8
4 1.6 1.8
5 3.8 3
6 6.4 0.9
7 1 0.9
8 1.2 1.6
9 8.1 4.9
10 27.2 0.8
11   2.3
12 1.8  
13 1.3  
14 5.4 1.3
15 3.1 3.6
16 6.6  
17 2.7 2.7
18 5.5 5.5
19 3.3 14.4
20 38.8  
21 12.4  
22 12.9 3.6
23 3.7 4.9
24 2.9 1.4
25 33.9 1.3
26 1 0.8
27 2.9 5.2
28 1.1  
29 1.1 5.8
30 1.6 1.2
31 5.2  

Table 8. The data of circulatory dynamics before and after exercise using the LEX in the first exercise session.

Blank space means that no data was measured.

'Before' column features data collected before the LEX exercise. 'After' column features data collected after the LEX exercise.

sBP: Systolic blood pressure [mmHg; dBP: Diastolic blood pressure [mmHg]; PR: Pulse rate [bpm]; SpO2: Saturation of percutaneous oxygen [%]; LEX: Leg exercise apparatus

  Before After Before After Before After Before After
Subject sBP sBP dBP dBP PR PR SpO2 SpO2
1 108 111 60 68 105 112 96 95
2 112 103 72 72 89 90 97 96
3 136 120 78 82 64 64 97 97
4   112   63   65   97
5 105 106 70 69 72 65 99 96
6 118 103 80 75 78 75   95
7 139 133 84 92 78 87 98 99
8                
9 131 144 86 100 83 82 95 95
10 150 152 73 75 73 70 98 98
11                
12 120 128 67 74 85 89 96 96
13 93 103     52 60 97 98
14 144 157 80 86 87 83 96 97
15 105 110 77 66 86 79 98 98
16 128 131 64 66 86 89 98 99
17 147 151 77 88 80 89 98 98
18 136 145 97 98 99 98 97 96
19 151 156 95 96 81 79 99 99
20 141 136 78 94 77 71 96 95
21 137 139 90 89 78 82 97 97
22 146 127 89 92 70 69 94 96
23 156 163 77 79 102 107 95 95
24 130 124 69 79 58 60 95 95
25 142 140 96 90 91 93 98 98
26 139 138 89 88 80 83 98 98
27 116 130 76 76 75 68 97  
28 132 135 77 76 62 62 95 96
29 122 124 64 58 58 58 97 97
30 109 116 64 67 80 82 98 97
31 157 160 77 78 76 78 97 98

Table 9. The data of circulatory dynamics before and after exercise using the LEX in the last exercise session.

Blank space means that no data was measured.

'Before' column features data collected before the LEX exercise. 'After' column features data collected after the LEX exercise.

sBP: Systolic blood pressure [mmHg; dBP: Diastolic blood pressure [mmHg]; PR: Pulse rate [bpm]; SpO2: Saturation of percutaneous oxygen [%]; LEX: Leg exercise apparatus

  Before After Before After Before After Before After
Subject sBP sBP dBP dBP PR PR SpO2 SpO2
1                
2                
3                
4                
5                
6                
7                
8                
9 126 128 72 76 72 74 98 98
10                
11                
12 108 111 62 66 89 88 98 98
13                
14 118 120 64 66 73 74 97 97
15 126 126 64 65 68 70 98 98
16 120 121 59 55 90 92 98 98
17 112 121 72 70 78 80 98 98
18 132 134 78 78 96 98 98 98
19 129 130 85 80 81 80 99 99
20 125 135 72 81 70 91 96 97
21 121 124 78 76 75 77 98 98
22 120 118 62 52 63 62 97 97
23 164 169 67 70 72 66 98 97
24 118 112 76 77 56 56 97 97
25 148 142 79 78 82 80 98 98
26 148 142 82 76 82 88 98 98
27                
28                
29 116 118 62 64 56 58 98 98
30 114 117 62 68 75 78 98 98
31 114 120 63 70 66 68 98 98

Table 10. The data of circumference of lower limb on the first day and the last day of the LEX exercise.

Blank space means that no data was measured.

'First' column features data from the first session of the LEX exercise. 'Last' column features data from the last session of the LEX exercise.

The maximum calf circumference was taken in cm. The thigh circumference (cm) was measured 10 cm above the patella. 

  First Last First Last First Last First Last
Subject Right calf Right calf Right thigh Right thigh Left calf Left calf Left thigh Left thigh
1 25 24.5 28 31.5 25 24.5 30 29.5
2 30.5 29.5 41 40 30 30.5 41.5 40.5
3 28.5 28.5 38 37 28.5 29 36 37
4 31.3   37.5   30.8   37  
5 28   35.5   27.5   35.5  
6 28.5   36.5   28   37  
7 23.5   31   23.5   31  
8 29.4 28.5 41.2 37.7 30.5 29.5 41 37.3
9 32.5 33 45 45 33 33 45 45
10 25.8   33   26.1   32.7  
11                
12 25 24.5 29.5 29 25 24.5 28.5 29
13 27.5   32.5   28   33  
14 31 31 40 40.5 31.5 31 40 40.5
15 35.5 35.8 43.5 43.5 36.5 35.5 44.5 45
16 29.5 28.5 35 34 29 28 35 35
17 23.5 23 28.5 28 23.5 23 29.5 29
18 28 27.5 42.5 43 28 28 38 38.5
19 29.4 38.5 34.8 35 29.5 38.7 35.7 35.2
20 32 31.1 38.9 38.3 32.5 32.1 40 36.9
21 31 31.2 39 38.8 31 31 38.5 38.5
22 32.6 32.5 40.3 39.8 32.1 32 40.3 39.5
23 31 28.7 34 34.5 31 29.5 35 34.5
24 36.9 35.1 43.7 43.2 36.8 33.1 44 44.3
25 32 31.5 39.5 39.3 32 31.3 39 39.2
26 27.5 27.5 36 36 27.5 27.5 36 36
27 28.5   32.5   29.5   34.5  
28 31.5   36   31   36  
29 37.5 37.5 49 48.5 38 37.5 49 48
30 35.5 35 43.5 43.5 35 35 43.5 43
31 35.5 33.5 41.5 40 36 33 41.5 40

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. Tsukuba Clinical Research & Development Organization issued approval H29-182. This study was approved by the institutional review board of the hospital (No. H29-182).

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Incidence, characteristics and management of venous thromboembolism in Japan during 2011. Ota S, Matsuda A, Ogihara Y, et al. Circ J. 2018;82:555–560. doi: 10.1253/circj.CJ-17-0579. [DOI] [PubMed] [Google Scholar]
  • 2.Thromboembolism prophylaxis in orthopaedics: an update. Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. EFORT Open Rev. 2018;3:136–148. doi: 10.1302/2058-5241.3.170018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Comparative study of the prevalence of venous thromboembolism after elective spinal surgery. Yoshioka K, Murakami H, Demura S, et al. Orthopedics. 2013;36:0. doi: 10.3928/01477447-20130122-26. [DOI] [PubMed] [Google Scholar]
  • 4.Venous thromboembolism prophylaxis in elective spine surgery. Solaru S, Alluri RK, Wang JC, Hah RJ. Global Spine J. 2021;11:1148–1155. doi: 10.1177/2192568220962439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Time-to-event analyses of lower-limb venous thromboembolism in aged patients undergoing lumbar spine surgery: a retrospective study of 1620 patients. Li L, Li Z, Huo Y, Yang D, Ding W, Yang S. Aging (Albany NY) 2019;11:8701–8709. doi: 10.18632/aging.102364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Venous thromboembolism events following spinal fractures: a single center experience. Cloney MB, Yamaguchi JT, Dhillon ES, Hopkins B, Smith ZA, Koski TR, Dahdaleh NS. Clin Neurol Neurosurg. 2018;174:7–12. doi: 10.1016/j.clineuro.2018.08.030. [DOI] [PubMed] [Google Scholar]
  • 7.Thromboembolic events after traumatic vertebral fractures: an analysis of 190,192 patients. Samuel AM, Diaz-Collado PJ, Gala RJ, et al. Spine (Phila Pa 1976) 2018;43:1289–1295. doi: 10.1097/BRS.0000000000002634. [DOI] [PubMed] [Google Scholar]
  • 8.Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Falck-Ytter Y, Francis CW, Johanson NA, et al. Chest. 2012;141:0. doi: 10.1378/chest.11-2404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Prevention of VTE in patients having major orthopedic surgery. Francis CW. J Thromb Thrombolysis. 2013;35:359–367. doi: 10.1007/s11239-013-0889-9. [DOI] [PubMed] [Google Scholar]
  • 10.Kushner A, West WP, Pillarisetty LS. Treasure Island (FL): StatPearls Publishing: StatPearls [Internet]; 2021. Virchow Triad. [PubMed] [Google Scholar]
  • 11.Muscle activity in the lower limbs during push-down movement with a new active-exercise apparatus for the leg. Tanaka K, Kamada H, Shimizu Y, et al. J Phys Ther Sci. 2016;28:1050–1054. doi: 10.1589/jpts.28.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.A novel apparatus for active leg exercise improves venous flow in the lower extremity. Shimizu Y, Kamada H, Sakane M, et al. https://www.minervamedica.it/en/journals/sports-med-physical-fitness/article.php?cod=R40Y2016N12A1592. J Sports Med Phys Fitness. 2016;56:1592–1597. [PubMed] [Google Scholar]
  • 13.The use of a novel in-bed active leg exercise apparatus (LEX) for increasing venous blood flow. Tanaka K, Kamada H, Shimizu Y, et al. J Rural Med. 2016;11:11–16. doi: 10.2185/jrm.2906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.A novel exercise device for venous thromboembolism prophylaxis improves venous flow in bed versus ankle movement exercises in healthy volunteers. Shimizu Y, Kamada H, Sakane M, et al. J Orthop Surg (Hong Kong) 2017;25 doi: 10.1177/2309499017739477. [DOI] [PubMed] [Google Scholar]
  • 15.The Borg scale is accurate in children and adolescents older than 9 years with cystic fibrosis. Hommerding PX, Donadio MV, Paim TF, et al. http://rc.rcjournal.com/content/respcare/55/6/729.full.pdf. Respir Care. 2010;55:729–733. [PubMed] [Google Scholar]
  • 16.The incidence of thoracic vertebral fractures in a Japanese population, Hiroshima and Nagasaki, 1958-1986. Fujiwara S, Mizuno S, Ochi Y, et al. J Clin Epidemiol. 1991;44:1007–1014. doi: 10.1016/0895-4356(91)90002-q. [DOI] [PubMed] [Google Scholar]
  • 17.Vertebral fragility fractures - how to treat them? Ferreira ML, March L. Best Pract Res Clin Rheumatol. 2019;33:227–235. doi: 10.1016/j.berh.2019.03.017. [DOI] [PubMed] [Google Scholar]
  • 18.Venous thromboembolism: a public health concern. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Am J Prev Med. 2010;38:0. doi: 10.1016/j.amepre.2009.12.017. [DOI] [PubMed] [Google Scholar]
  • 19.An overview of clinical guidelines for the management of vertebral compression fracture: a systematic review. Parreira PC, Maher CG, Megale RZ, March L, Ferreira ML. Spine J. 2017;17:1932–1938. doi: 10.1016/j.spinee.2017.07.174. [DOI] [PubMed] [Google Scholar]
  • 20.Guideline for safety management and promotion in rehabilitation medicine. Maeda Maeda, M M. Jpn J Rehabil Med. 2007;44:384–390. [Google Scholar]
  • 21.Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. Horsted F, West J, Grainge MJ. PLoS Med. 2012;9:0. doi: 10.1371/journal.pmed.1001275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis. Melis F, Vandenbrouke JP, Büller HR, Colly LP, Bloemenkamp KW. Am J Obstet Gynecol. 2004;191:825–829. doi: 10.1016/j.ajog.2004.02.004. [DOI] [PubMed] [Google Scholar]
  • 23.COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Di Minno A, Ambrosino P, Calcaterra I, Di Minno MN. Semin Thromb Hemost. 2020;46:763–771. doi: 10.1055/s-0040-1715456. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES